Cargando…
Treatment of very high-risk classical Hodgkin Lymphoma: cases’ selection from real life and critical review of the literature
Over the last 4 decades, advances in radiation therapy and the addition of combination chemotherapy have significantly increased the cure rate of patients with HL, with a 5-year OS of about 90% . However, despite high rate of cure after first line of therapy, 5%-10% of HLs are refractory to the trea...
Autores principales: | Rusconi, Chiara, Ciavarella, Sabino, Fabbri, Alberto, Flenghi, Leonardo, Puccini, Benedetta, Re, Alessandro, Sorio, Marco, Vanazzi, Anna, Zanni, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944652/ https://www.ncbi.nlm.nih.gov/pubmed/32525130 http://dx.doi.org/10.23750/abm.v91iS-5.9911 |
Ejemplares similares
-
Advanced stage Hodgkin Lymphoma: patient management
por: Gini, Guido, et al.
Publicado: (2020) -
Hodgkin’s lymphoma: post- autologous transplantation consolidation therapy
por: Merli, Francesco, et al.
Publicado: (2020) -
Allogeneic Hematopoietic Cell Transplantation in the Treatment of Chronic Lymphocytic Leukemia: Why and When?
por: Delioukina, Maria L., et al.
Publicado: (2010) -
Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Disease. Unicenter Experience in a Multi-Ethnic Population.
por: Marziali, Marco, et al.
Publicado: (2009) -
Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)